<div class="article-table-content" id="dme13817-tbl-0002">
               <header class="article-table-caption"><span class="table-caption__label">Table 2.
            </span>Safety characteristics according to diabetes status at baseline in the pool of 14 phase 2/3 trials (safety population)
               </header><div class="article-table-content-wrapper">
                  <table class="table article-section__table">
<thead>
<tr>
<th class="right-bordered-cell left-aligned"></th>
                           
                           <th colspan="2" class="bottom-bordered-cell center-aligned">People with diabetes <i>N</i> = 1554
                           </th>
                           
                           <th colspan="2" class="bottom-bordered-cell center-aligned">People without diabetes <i>N</i> = 3680
                           </th>
                           
                        </tr>
<tr>
<th class="bottom-bordered-cell right-bordered-cell left-aligned">
<i>n</i> (%)
                           </th>
                           
                           <th class="bottom-bordered-cell center-aligned">Control <i>n</i> = 558
                           </th>
                           
                           <th class="bottom-bordered-cell center-aligned">Alirocumab <i>n</i> = 996
                           </th>
                           
                           <th class="bottom-bordered-cell center-aligned">Control <i>n</i> = 1336
                           </th>
                           
                           <th class="bottom-bordered-cell center-aligned">Alirocumab <i>n</i> = 2344
                           </th>
                           
                        </tr>
</thead>
<tbody>
<tr>
<td class="right-bordered-cell left-aligned">TEAEs</td>
                           
                           <td class="center-aligned">431 (77.2)</td>
                           
                           <td class="center-aligned">781 (78.4)</td>
                           
                           <td class="center-aligned">1030 (77.1)</td>
                           
                           <td class="center-aligned">1818 (77.6)</td>
                           
                        </tr>
<tr>
<td class="right-bordered-cell left-aligned">Serious TEAEs</td>
                           
                           <td class="center-aligned">110 (19.7)</td>
                           
                           <td class="center-aligned">193 (19.4)</td>
                           
                           <td class="center-aligned">181 (13.5)</td>
                           
                           <td class="center-aligned">341 (14.5)</td>
                           
                        </tr>
<tr>
<td class="right-bordered-cell left-aligned">TEAEs leading to death</td>
                           
                           <td class="center-aligned">7 (1.3)</td>
                           
                           <td class="center-aligned">9 (0.9)</td>
                           
                           <td class="center-aligned">15 (1.1)</td>
                           
                           <td class="center-aligned">13 (0.6)</td>
                           
                        </tr>
<tr>
<td class="right-bordered-cell left-aligned">TEAEs leading to discontinuation</td>
                           
                           <td class="center-aligned">43 (7.7)</td>
                           
                           <td class="center-aligned">87 (8.7)</td>
                           
                           <td class="center-aligned">94 (7.0)</td>
                           
                           <td class="center-aligned">145 (6.2)</td>
                           
                        </tr>
</tbody>
</table>
</div>
               
               
               
               <div class="article-section__table-footnotes">
                  <ul>
<li id="dme13817-note-0006">
                        AE, adverse event; TEAE, treatment‚Äêemergent adverse event.
                        
                     </li>
                  </ul>
</div>
               <div class="article-section__table-source"></div>
            </div>